AAAAAA
Results:
1-24
|
Results: 24
Authors:
Roschger, P
Rinnerthaler, S
Yates, J
Rodan, GA
Fratzl, P
Klaushofer, K
Citation: P. Roschger et al., Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women, BONE, 29(2), 2001, pp. 185-191
Authors:
Weinreb, M
Machwate, M
Shir, N
Abramovitz, M
Rodan, GA
Harada, S
Citation: M. Weinreb et al., Expression of the prostaglandin E-2 (PGE(2)) receptor subtype EP4 and its regulation by PGE(2) in osteoblastic cell lines and adult rat bone tissue, BONE, 28(3), 2001, pp. 275-281
Authors:
Machwate, M
Harada, S
Leu, CT
Seedor, G
Labelle, M
Gallant, M
Hutchins, S
Lachance, N
Sawyer, N
Slipetz, D
Metters, KM
Rodan, SB
Young, R
Rodan, GA
Citation: M. Machwate et al., Prostaglandin receptor EP4 mediates the bone anabolic effects of PGE(2), MOLEC PHARM, 60(1), 2001, pp. 36-41
Authors:
Reszka, AA
Halasy-Nagy, J
Rodan, GA
Citation: Aa. Reszka et al., Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation, MOLEC PHARM, 59(2), 2001, pp. 193-202
Authors:
Lakkakorpi, PT
Nakamura, I
Young, M
Lipfert, L
Rodan, GA
Duong, LT
Citation: Pt. Lakkakorpi et al., Abnormal localisation and hyperclustering of alpha(v)beta(3) integrins andassociated proteins in Src-deficient or tyrphostin A9-treated osteoclasts, J CELL SCI, 114(1), 2001, pp. 149-160
Authors:
Nakamura, I
Lipfert, L
Rodan, GA
Duong, LT
Citation: I. Nakamura et al., Convergence of alpha(v)beta(3) integrin- and macrophage colony stimulatingfactor-mediated signals on phospholipase C gamma in prefusion osteoclasts, J CELL BIOL, 152(2), 2001, pp. 361-373
Authors:
Duong, LT
Nakamura, I
Lakkakorpi, PT
Lipfert, L
Bett, AJ
Rodan, GA
Citation: Lt. Duong et al., Inhibition of osteoclast function by adenovirus expressing antisense protein-tyrosine kinase 2, J BIOL CHEM, 276(10), 2001, pp. 7484-7492
Authors:
Opas, EE
Gentile, MA
Rossert, JA
De Crombrugghe, B
Rodan, GA
Schmidt, A
Citation: Ee. Opas et al., Parathyroid hormone and prostaglandin E-2 preferentially increase luciferase levels in bone of mice harboring a luciferase transgene controlled by elements of the pro-alpha 1(I) collagen promoter, BONE, 26(1), 2000, pp. 27-32
Authors:
Duong, L
Lakkakorpi, P
Nakamura, I
Rodan, GA
Citation: L. Duong et al., Integrins and signaling in osteoclast function, MATRIX BIOL, 19(2), 2000, pp. 97-105
Authors:
Duong, LT
Rodan, GA
Citation: Lt. Duong et Ga. Rodan, PYK2 is an adhesion kinase in macrophages, localized in podosomes and activated by beta(2)-integrin ligation, CELL MOTIL, 47(3), 2000, pp. 174-188
Authors:
Rodan, GA
Martin, TJ
Citation: Ga. Rodan et Tj. Martin, Therapeutic approaches to bone diseases, SCIENCE, 289(5484), 2000, pp. 1508-1514
Authors:
Duggan, ME
Duong, LT
Fisher, JE
Hamill, TG
Hoffman, WF
Huff, JR
Ihle, NC
Leu, CT
Nagy, RM
Perkins, JJ
Rodan, SB
Wesolowski, G
Whitman, DB
Zartman, AE
Rodan, GA
Hartman, GD
Citation: Me. Duggan et al., Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist, J MED CHEM, 43(20), 2000, pp. 3736-3745
Authors:
Fisher, JE
Rodan, GA
Reszka, AA
Citation: Je. Fisher et al., In vivo effects of bisphosphonates on the osteoclast mevalonate pathway, ENDOCRINOL, 141(12), 2000, pp. 4793-4796
Authors:
Peter, C
Rodan, GA
Citation: C. Peter et Ga. Rodan, Preclinical safety profile of alendronate, INT J CL PR, 1999, pp. 3-8
Authors:
Hayes, WC
Shea, M
Rodan, GA
Citation: Wc. Hayes et al., Preclinical evidence of normal bone with alendronate, INT J CL PR, 1999, pp. 9-13
Authors:
Gil, L
Han, YX
Opas, EE
Rodan, GA
Ruel, R
Seedor, JG
Tyler, PC
Young, RN
Citation: L. Gil et al., Prostaglandin E-2-bisphosphonate conjugates: Potential agents for treatment of osteoporosis, BIO MED CH, 7(5), 1999, pp. 901-919
Authors:
Schmidt, A
Vogel, R
Holloway, MK
Rutledge, SJ
Friedman, O
Yang, ZL
Rodan, GA
Friedman, E
Citation: A. Schmidt et al., Transcription control and neuronal differentiation by agents that activatethe LXR nuclear receptor family, MOL C ENDOC, 155(1-2), 1999, pp. 51-60
Authors:
Fisher, JE
Rogers, MJ
Halasy, JM
Luckman, SP
Hughes, DE
Masarachia, PJ
Wesolowski, G
Russell, RGG
Rodan, GA
Reszka, AA
Citation: Je. Fisher et al., Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro, P NAS US, 96(1), 1999, pp. 133-138
Authors:
Lafage-Proust, MH
Wesolowski, G
Ernst, M
Rodan, GA
Rodan, SB
Citation: Mh. Lafage-proust et al., Retinoic acid effects on an SV-40 large T antigen immortalized adult rat bone cell line, J CELL PHYS, 179(3), 1999, pp. 267-275
Authors:
Nakamura, I
Pilkington, MF
Lakkakorpi, PT
Lipfert, L
Sims, SM
Dixon, SJ
Rodan, GA
Duong, LT
Citation: I. Nakamura et al., Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone, J CELL SCI, 112(22), 1999, pp. 3985-3993
Authors:
Lakkakorpi, PT
Nakamura, I
Nagy, RM
Parsons, JT
Rodan, GA
Duong, LT
Citation: Pt. Lakkakorpi et al., Stable association of PYK2 and p(130)Cas in their co-localization in the sealing zone, J BIOL CHEM, 274(8), 1999, pp. 4900-4907
Authors:
Reszka, AA
Halasy-Nagy, JM
Masarachia, PJ
Rodan, GA
Citation: Aa. Reszka et al., Bisphosphonates act directly on the osteoclast to induce caspase cleavage of Mst1 kinase during apoptosis - A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase, J BIOL CHEM, 274(49), 1999, pp. 34967-34973
Authors:
Jimi, E
Nakamura, I
Duong, LT
Ikebe, T
Takahashi, N
Rodan, GA
Suda, T
Citation: E. Jimi et al., Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells, EXP CELL RE, 247(1), 1999, pp. 84-93
Authors:
Rodan, GA
Citation: Ga. Rodan, Control of bone formation and resorption: Biological and clinical perspective, J CELL BIOC, 1998, pp. 55-61
Risultati:
1-24
|